These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 1347740

  • 21. Hormonal deinduction of tyrosine aminotransferase.
    Giesen EM, Beck G.
    Horm Metab Res; 1982 May; 14(5):252-6. PubMed ID: 6124498
    [Abstract] [Full Text] [Related]

  • 22. Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells.
    Kathju S, Heaton JH, Bruzdzinski CJ, Gelehrter TD.
    Endocrinology; 1994 Sep; 135(3):1195-204. PubMed ID: 8070363
    [Abstract] [Full Text] [Related]

  • 23. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells.
    Crettaz M, Muller-Wieland D, Kahn CR.
    Biochemistry; 1988 Jan 12; 27(1):495-500. PubMed ID: 2894848
    [Abstract] [Full Text] [Related]

  • 24. Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity. Mediation by glucocorticoid receptors.
    Barouski-Miller PA, Gelehrter TD.
    J Steroid Biochem; 1984 Feb 12; 20(2):533-7. PubMed ID: 6142981
    [Abstract] [Full Text] [Related]

  • 25. Description and analysis of differential sensitivity to glucocorticoids in Fao cells.
    Gagne D, Labhilili M, Pons M.
    J Steroid Biochem; 1988 Dec 12; 31(6):917-25. PubMed ID: 2904511
    [Abstract] [Full Text] [Related]

  • 26. Steroid specificity of the glucocorticoid inhibition of amino acid transport in rat hepatoma cells.
    Gelehrter TD, McDonald RA.
    Endocrinology; 1981 Aug 12; 109(2):476-82. PubMed ID: 6113950
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A.
    Celander M, Hahn ME, Stegeman JJ.
    Arch Biochem Biophys; 1996 May 01; 329(1):113-22. PubMed ID: 8619627
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cross-talk modulation of signal transduction pathways: two mechanisms are involved in the control of tyrosine aminotransferase gene expression by phorbol esters.
    Reik A, Stewart AF, Schütz G.
    Mol Endocrinol; 1994 Apr 01; 8(4):490-7. PubMed ID: 7914348
    [Abstract] [Full Text] [Related]

  • 31. Modulation of TAT gene induction by glucocorticoids involves a neutralizing sequence.
    Jackson DA, Collier CD, Oshima H, Simons SS.
    J Steroid Biochem Mol Biol; 1998 Aug 01; 66(3):79-91. PubMed ID: 9719442
    [Abstract] [Full Text] [Related]

  • 32. Age-related changes in the induction of tyrosine aminotransferase by dexamethasone: correlation with the low-affinity glucocorticoid binding sites.
    Chirino R, Fernández L, López-Guerra A, Valerón PF, Navarro D, Díaz-Chico JC, Díaz-Chico BN.
    Mech Ageing Dev; 1994 Sep 01; 75(3):227-38. PubMed ID: 7845056
    [Abstract] [Full Text] [Related]

  • 33. Glucocorticoid responsiveness of hepatoma cell hybrids.
    Venetianer A, Gál A, Bösze Z.
    Acta Biol Acad Sci Hung; 1981 Sep 01; 32(3-4):175-88. PubMed ID: 6127852
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of N-methyl-N'-nitro-N-nitrosoguanidine on constitutive and hormone-inducible gene expression in rat hepatoma cells.
    Miller MS.
    Chem Biol Interact; 1990 Sep 01; 73(2-3):207-19. PubMed ID: 1690087
    [Abstract] [Full Text] [Related]

  • 35. Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes.
    Mitsuyoshi H, Nakashima T, Inaba K, Ishikawa H, Nakajima Y, Sakamoto Y, Matsumoto M, Okanoue T, Kashima K.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):732-6. PubMed ID: 9398635
    [Abstract] [Full Text] [Related]

  • 36. The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells.
    Heiman AS, Tonner LE.
    Toxicology; 1995 Jun 26; 100(1-3):57-68. PubMed ID: 7624883
    [Abstract] [Full Text] [Related]

  • 37. Spironolactone: a glucocorticoid agonist or antagonist?
    Campen TJ, Fanestil DD.
    Clin Exp Hypertens A; 1982 Jun 26; 4(9-10):1627-36. PubMed ID: 6128090
    [Abstract] [Full Text] [Related]

  • 38. Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver.
    Merkulova TI, Kropachev KY, Timofeeva OA, Vasiliev GV, Levashova ZB, Ilnitskaya SI, Kobzev VF, Pakharukova MY, Bryzgalov LO, Kaledin VI.
    Mol Carcinog; 2005 Dec 26; 44(4):223-32. PubMed ID: 16267830
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture.
    Martin D, Tomkins GM, Granner D.
    Proc Natl Acad Sci U S A; 1969 Jan 26; 62(1):248-55. PubMed ID: 4388856
    [Abstract] [Full Text] [Related]

  • 40. Induction of tyrosine aminotransferase activity by concanavalin A in cultured rat hepatoma cells.
    Sorimachi K, Yasumura Y.
    Jpn J Exp Med; 1983 Feb 26; 53(1):33-9. PubMed ID: 6135812
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.